Aurobindo Pharma Ltd

AUROPHARMA
Health CarePharmaceuticals
MidcapWith a market cap of ₹38,777 cr, stock is ranked 130
Low RiskStock is 1.92x as volatile as Nifty
661.8012.35 (-1.83%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹38,777 cr, stock is ranked 130
Low RiskStock is 1.92x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
7.27
PB RatioPB Ratio
1.77
Dividend YieldDiv. Yield
0.60%
Sector PESector PE
37.55
Sector PBSector PB
5.01
Sector Div YldSctr Div Yld
0.69%

Forecast & RatingsDetailed Forecast 

83%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs).

Brands

Aurobindo Pharma

Pharmaceutical company

Investor PresentationView older 

Nov 8, 2021

PDF
View Older Presentations

Brands

Aurobindo Pharma

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201820192020202116.5719.7223.2928.402.422.362.855.33
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Copy of Newspaper Publication 
Announced OnNov 29, 2021

Aurobindo Pharma Limited has informed the Exchange about Copy of Newspaper Publication | Download

Aurobindo Pharma Limited has informed the Exchange about Copy of Newspaper Publication | Download

Analysts/Institutional Investor Meet/Con. Call Updates 
Announced OnNov 19, 2021

Aurobindo Pharma Limited has informed the Exchange about Transcript | Download

Aurobindo Pharma Limited has informed the Exchange about Transcript | Download

Cash Dividend 
Ex. DateNov 17, 2021

Interim 2 • Div/Share: ₹ 1.5

See all events